
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+14
Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995. We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website. The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the...
Immunology,antibodies,monoclonal antibodies,polyclonal antibodies,recombinant protein,peptide synthesis,antibody labelling,dna immunization,primary antibodies,secondary antibodies,antibody purification,custom antibody,immunoassay,elisa,custom project,antibody design,vhh,covid19,and ecl reagent
Covalab operates in the Biotechnology industry.
Covalab's revenue is 11m - 100m
Covalab has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.